XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock and Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Common stock, beginning balance (in shares) at Dec. 31, 2023   58,295,491    
Stockholders' equity (deficit), beginning balance at Dec. 31, 2023 $ 366,919 $ 1,484,056 $ (1,117,170) $ 33
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units and restricted shares (in shares)   657,579    
Vesting of restricted stock units and restricted shares 0      
Exercise of stock options (in shares)   3,062    
Exercise of stock options 20 $ 20    
Stock-based compensation 11,015 $ 11,015    
Net loss (20,587)   (20,587)  
Other comprehensive income (loss) (157)     (157)
Common stock, ending balance (in shares) at Mar. 31, 2024   58,956,132    
Stockholders' equity (deficit), ending balance at Mar. 31, 2024 $ 357,210 $ 1,495,091 (1,137,757) (124)
Common stock, beginning balance (in shares) at Dec. 31, 2024 64,043,799 64,043,799    
Stockholders' equity (deficit), beginning balance at Dec. 31, 2024 $ 365,207 $ 1,552,714 (1,186,672) (835)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units and restricted shares (in shares)   980,857    
Vesting of restricted stock units and restricted shares 0      
Stock-based compensation 7,787 $ 7,787    
Repurchase of common stock (in shares)   (1,103,601)    
Repurchase of common stock (5,000) $ (5,000)    
Issuance of common stock related to acquisition (in shares)   5,560,583    
Issuance of common stock related to acquisition 31,584 $ 31,584    
Net loss (23,742)   (23,742)  
Other comprehensive income (loss) $ 975     975
Common stock, ending balance (in shares) at Mar. 31, 2025 69,481,638 69,481,638    
Stockholders' equity (deficit), ending balance at Mar. 31, 2025 $ 376,811 $ 1,587,085 $ (1,210,414) $ 140